An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia

NCT05276830 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated for business reasons; not due to safety or efficacy concerns

Conditions

Interventions

Sponsor

BioXcel Therapeutics Inc

Collaborators